EDIUNET Free equity investment tool of Japanese companies

Companies Cart
@
Financial Statement Details
Annual
First quarter
Second quarter
Third quarter
Sponsored Link
Related Company
@ POLA ORBIS HOLDINGS +
@ 参天製薬 +
@ FUJIKURA KASEI +
@ ZEON +
@ 和光純薬工業 +
@ 日油 +
@ NITTO FC +
@ 日本曹達 +
@ MUTO SEIKO CO. +
@ Sumitomo Seika Chemicals +
@ KAKEN PHARMACEUTICAL +
@ EBARA-UDYLITE  +
@ KUREHA +
@ MITSUBISHI PLASTICS +
@ SATO PHARMACEUTICAL +
EDIUNET Related Ranking
EDIUNET
EDIUNET Credit Rating
EDIUNET Industry Avg
EDIUNET Prefectures
Yuho! Industry
EDIUNET Rating News
Prev « 2024-04 » Next
Mon Tue Wed Thu Fri Sat Sun
1
-
2
-
3
-
4
-
5
-
6
-
7
-
8
-
9
-
10
-
11
-
12
-
13
-
14
-
15
-
16
-
17
-
18
-
19
-
20
-
21
-
22
-
23
-
24
-
25
-
26
-
27
-
28
-
29
-
30
-
[Update list]
1/28 Retail Trade (CAWACHI:A etc...
1/27 Banks (The Awa Bank:BBB→A)
1/23 Chemicals (Milbon:AA→AAA)
1/21 Glass & Ceramics Products (..
1/21 Machinery (TSUDAKOMA:C)
1/21 Other Services (Netindex.:CC)
1/20 Other Products (Kurogane Kos..
1/20 Wholesale Trade (リーバイ・..
1/20 Other Services (川崎地質:BB→..
1/17 Chemicals (Kawaguchi Chemica..
 RSS
 Company RSS
 Daily RSS
Sponsored Link
Recently Download Chart
クラリオン
graph
クラリオン
graph
クラリオン
graph
クラリオン
graph
PIONEER etc.
graph

Financial Statement Details: Nissui Pharmaceutical (Annual )

Two or more periods are displayed by each of subject collectively.Two or more companies can be compared and financial statement data can also be downloaded.

【Analysis Menu】 @Outline @Statement @Rating @Indicator @Download

Sponsored Link

*Free Download Financial Statement data

U-Chart(pie chart)2009-03-312010-03-312011-03-31
  • Cash etc.
  • Other Current Assets
  • Tangible Assets
  • Intangible Assets
  • Investment etc.
  • Current Liabilities
  • Fixed Liabilities
  • Capital stock
  • Capital surplus etc.
*IN(*Right half), OUT(*Left half), BALANCE(*Net Assets)
[BS] 2009-03-31
 *  Total: ¥ 26 B
 *  Net: ¥ 22 B
 (Ratio: 87.80%)
[BS] 2010-03-31
 *  Total: ¥ 27 B
 *  Net: ¥ 23 B
 (Ratio: 87.50%)
[BS] 2011-03-31
 *  Total: ¥ 27 B
 *  Net: ¥ 24 B
 (Ratio: 88.13%)
Financial Statement Details2009-03-312010-03-312011-03-31
Cash etc. ¥ 1 B ¥ 2 B ¥ 3 B
Other Current Assets ¥ 11 B ¥ 10 B ¥ 10 B
Tangible Assets ¥ 5 B ¥ 4 B ¥ 5 B
Intangible Assets ¥ 114 M ¥ 96 M ¥ 102 M
Investment etc. ¥ 6 B ¥ 9 B ¥ 7 B
Total Assets ¥ 26 B ¥ 27 B ¥ 27 B
Current Liabilities ¥ 2 B ¥ 2 B ¥ 2 B
Fixed Liabilities ¥ 850 M ¥ 851 M ¥ 857 M
Capital stock ¥ 4 B ¥ 4 B ¥ 4 B
Capital surplus etc. ¥ 18 B ¥ 19 B ¥ 19 B
Liabilities and net assets ¥ 26 B ¥ 27 B ¥ 27 B
U-Chart(pie chart)2009-03-312010-03-312011-03-31
  • Sales
  • Cost of Sales
  • Other income
  • SG&A
  • Other expenses
  • Net income
*IN(*Right half), OUT(*Left half), BALANCE(*Net Income)
[PL] 2009-03-31
 *  Sales: ¥ 14 B
 *  Income: ¥ 449 M
 (Ratio: 3.12%)
[PL] 2010-03-31
 *  Sales: ¥ 12 B
 *  Income: ¥ 920 M
 (Ratio: 7.39%)
[PL] 2011-03-31
 *  Sales: ¥ 13 B
 *  Income: ¥ 1 B
 (Ratio: 9.58%)
Financial Statement Details2009-03-312010-03-312011-03-31
Sales ¥ 14 B ¥ 12 B ¥ 13 B
Cost of Sales ¥ 7 B ¥ 6 B ¥ 6 B
Gross profit ¥ 6 B ¥ 6 B ¥ 6 B
Other income ¥ 424 M ¥ 521 M ¥ 507 M
SG&A ¥ 5 B ¥ 4 B ¥ 4 B
Other expenses ¥ 1 B ¥ 987 M ¥ 1 B
Net income ¥ 449 M ¥ 920 M ¥ 1 B
U-Chart(pie chart)2009-03-312010-03-312011-03-31
  • Operating CF
  • Investment CF
  • Financial CF
  • Foreign Exchange Effects
  • Net Change in Cash
*IN(*Right half), OUT(*Left half), BALANCE(*Net Change in Cash)
[CF] 2009-03-31
 *  OCF: ¥ 1 B
 *  Cash: ¥ -822 M
[CF] 2010-03-31
 *  OCF: ¥ 2 B
 *  Cash: ¥ +1 B
[CF] 2011-03-31
 *  OCF: ¥ 1 B
 *  Cash: ¥ +210 M
Financial Statement Details2009-03-312010-03-312011-03-31
Operating CF ¥ 1 B ¥ 2 B ¥ 1 B
Investment CF ¥ -1 B ¥ -195 M ¥ -602 M
Financial CF ¥ -430 M ¥ -453 M ¥ -814 M
Foreign Exchange Effects - - -
Net Change in Cash ¥ -822 M ¥ 1 B ¥ 210 M
U-Chart(pie chart)2009-03-312010-03-312011-03-31
  • Issuance of new shares
  • Dividends from surplus
  • Net income
  • Purchase of treasury stock
  • Other Change in Stockholders Equity
  • Other Change in Net Assets
  • Net Change in Net Assets
*IN(*Right half), OUT(*Left half), BALANCE(*Net Change in Net Assets)
[SS] 2009-03-31
 *  Income: ¥ 449 M
 *  Net: ¥ -450 M
[SS] 2010-03-31
 *  Income: ¥ 920 M
 *  Net: ¥ +938 M
[SS] 2011-03-31
 *  Income: ¥ 1 B
 *  Net: ¥ +635 M
Financial Statement Details2009-03-312010-03-312011-03-31
Issuance of new shares - - -
Dividends from surplus ¥ -425 M ¥ -447 M ¥ -515 M
Net income ¥ 449 M ¥ 920 M ¥ 1 B
Purchase of treasury stock ¥ -985 K ¥ -711 K ¥ -523 K
Other Change in Stockholders Equity - - -
Other Change in Net Assets ¥ -473 M ¥ 466 M ¥ -121 M
Net Change in Net Assets ¥ -450 M ¥ 938 M ¥ 635 M
U-Chart(pie chart)2009-03-312010-03-312011-03-312012-03-312013-03-31
  • Cash etc.
  • Other Current Assets
  • Tangible Assets
  • Intangible Assets
  • Investment etc.
  • Current Liabilities
  • Fixed Liabilities
  • Capital stock
  • Capital surplus etc.
*IN(*Right half), OUT(*Left half), BALANCE(*Net Assets)
[BS] 2009-03-31
 *  Total: ¥ 25 B
 *  Net: ¥ 22 B
 (Ratio: 87.90%)
[BS] 2010-03-31
 *  Total: ¥ 27 B
 *  Net: ¥ 23 B
 (Ratio: 86.02%)
[BS] 2011-03-31
 *  Total: ¥ 27 B
 *  Net: ¥ 24 B
 (Ratio: 88.42%)
[BS] 2012-03-31
 *  Total: ¥ 28 B
 *  Net: ¥ 25 B
 (Ratio: 89.28%)
[BS] 2013-03-31
 *  Total: ¥ 30 B
 *  Net: ¥ 27 B
 (Ratio: 90.23%)
Financial Statement Details2009-03-312010-03-312011-03-312012-03-312013-03-31
Cash etc. ¥ 1 B ¥ 2 B ¥ 2 B ¥ 2 B ¥ 2 B
Other Current Assets ¥ 11 B ¥ 10 B ¥ 10 B ¥ 14 B ¥ 15 B
Tangible Assets ¥ 5 B ¥ 4 B ¥ 4 B ¥ 5 B ¥ 5 B
Intangible Assets ¥ 112 M ¥ 96 M ¥ 86 M ¥ 84 M ¥ 60 M
Investment etc. ¥ 7 B ¥ 9 B ¥ 9 B ¥ 6 B ¥ 7 B
Total Assets ¥ 25 B ¥ 27 B ¥ 27 B ¥ 28 B ¥ 30 B
Current Liabilities ¥ 2 B ¥ 2 B ¥ 2 B ¥ 2 B ¥ 2 B
Fixed Liabilities ¥ 842 M ¥ 851 M ¥ 849 M ¥ 485 M ¥ 472 M
Capital stock ¥ 4 B ¥ 4 B ¥ 4 B ¥ 4 B ¥ 4 B
Capital surplus etc. ¥ 17 B ¥ 18 B ¥ 19 B ¥ 20 B ¥ 23 B
Liabilities and net assets ¥ 25 B ¥ 27 B ¥ 27 B ¥ 28 B ¥ 30 B
U-Chart(pie chart)2009-03-312010-03-312011-03-312012-03-312013-03-31
  • Sales
  • Cost of Sales
  • Other income
  • SG&A
  • Other expenses
  • Net income
*IN(*Right half), OUT(*Left half), BALANCE(*Net Income)
[PL] 2009-03-31
 *  Sales: ¥ 12 B
 *  Income: ¥ 440 M
 (Ratio: 3.61%)
[PL] 2010-03-31
 *  Sales: ¥ 12 B
 *  Income: ¥ 1 B
 (Ratio: 8.73%)
[PL] 2011-03-31
 *  Sales: ¥ 12 B
 *  Income: ¥ 1 B
 (Ratio: 13.26%)
[PL] 2012-03-31
 *  Sales: ¥ 13 B
 *  Income: ¥ 1 B
 (Ratio: 12.06%)
[PL] 2013-03-31
 *  Sales: ¥ 13 B
 *  Income: ¥ 2 B
 (Ratio: 16.92%)
Financial Statement Details2009-03-312010-03-312011-03-312012-03-312013-03-31
Sales ¥ 12 B ¥ 12 B ¥ 12 B ¥ 13 B ¥ 13 B
Cost of Sales ¥ 6 B ¥ 6 B ¥ 6 B ¥ 6 B ¥ 6 B
Gross profit ¥ 6 B ¥ 6 B ¥ 5 B ¥ 6 B ¥ 6 B
Other income ¥ 448 M ¥ 645 M ¥ 907 M ¥ 647 M ¥ 661 M
SG&A ¥ 4 B ¥ 4 B ¥ 4 B ¥ 4 B ¥ 4 B
Other expenses ¥ 1 B ¥ 980 M ¥ 937 M ¥ 1 B ¥ 1 B
Net income ¥ 440 M ¥ 1 B ¥ 1 B ¥ 1 B ¥ 2 B
U-Chart(pie chart)2012-03-312013-03-31
  • Operating CF
  • Investment CF
  • Financial CF
  • Foreign Exchange Effects
  • Net Change in Cash
*IN(*Right half), OUT(*Left half), BALANCE(*Net Change in Cash)
[CF] 2012-03-31
 *  OCF: ¥ 1 B
 *  Cash: ¥ -1 B
[CF] 2013-03-31
 *  OCF: ¥ 1 B
 *  Cash: ¥ +777 M
Financial Statement Details2012-03-312013-03-31
Operating CF - -
Investment CF - -
Financial CF - -
Foreign Exchange Effects - -
Net Change in Cash - -
U-Chart(pie chart)2009-03-312010-03-312011-03-312012-03-312013-03-31
  • Issuance of new shares
  • Dividends from surplus
  • Net income
  • Purchase of treasury stock
  • Other Change in Stockholders Equity
  • Other Change in Net Assets
  • Net Change in Net Assets
*IN(*Right half), OUT(*Left half), BALANCE(*Net Change in Net Assets)
[SS] 2009-03-31
 *  Income: ¥ 440 M
 *  Net: ¥ -459 M
[SS] 2010-03-31
 *  Income: ¥ 1 B
 *  Net: ¥ +1 B
[SS] 2011-03-31
 *  Income: ¥ 1 B
 *  Net: ¥ +983 M
[SS] 2012-03-31
 *  Income: ¥ 1 B
 *  Net: ¥ +1 B
[SS] 2013-03-31
 *  Income: ¥ 2 B
 *  Net: ¥ +2 B
Financial Statement Details2009-03-312010-03-312011-03-312012-03-312013-03-31
Issuance of new shares - - - - -
Dividends from surplus ¥ -425 M ¥ -447 M ¥ -515 M ¥ -582 M ¥ -671 M
Net income ¥ 440 M ¥ 1 B ¥ 1 B ¥ 1 B ¥ 2 B
Purchase of treasury stock ¥ -985 K ¥ -711 K ¥ -523 K ¥ -273 K -
Other Change in Stockholders Equity ¥ 1 K - ¥ -1 K ¥ -1 K -
Other Change in Net Assets ¥ -473 M ¥ 466 M ¥ -116 M ¥ 4 M ¥ 700 M
Net Change in Net Assets ¥ -459 M ¥ 1 B ¥ 983 M ¥ 1 B ¥ 2 B

Consolidated :Balance sheet (Annual ) 2008-03-312009-03-312010-03-312011-03-31
   Cash and deposits¥ 2 B¥ 1 B¥ 2 B¥ 3 B
   Notes and accounts receivable-trade¥ 3 B¥ 3 B¥ 3 B¥ 3 B
    Short-term investment securities¥ 1 B¥ 234 M¥ 403 M¥ 1 B
    Merchandise and finished goods¥ 1 B¥ 1 B¥ 1 B
     Raw materials and supplies¥ 721 M¥ 629 M¥ 508 M
     Work in process¥ 346 M¥ 410 M¥ 310 M
   Deferred tax assets¥ 179 M¥ 176 M¥ 174 M¥ 163 M
    Deposit paid in subsidiaries and affiliates¥ 3 B¥ 4 B¥ 4 B¥ 3 B
    Allowance for doubtful accounts¥ -17 M¥ -18 M¥ -14 M¥ -14 M
   Other¥ 235 M¥ 218 M¥ 146 M¥ 146 M
   Current assets¥ 14 B¥ 13 B¥ 13 B¥ 14 B
    Buildings and structures¥ 6 B¥ 6 B¥ 6 B¥ 8 B
     Accumulated depreciation¥ -4 B¥ -4 B¥ -4 B¥ -5 B
     Buildings and structures, net¥ 2 B¥ 2 B¥ 2 B¥ 2 B
    Machinery, equipment and vehicles¥ 4 B¥ 4 B¥ 4 B¥ 5 B
     Accumulated depreciation¥ -4 B¥ -4 B¥ -4 B¥ -4 B
     Machinery, equipment and vehicles, net¥ 505 M¥ 803 M¥ 565 M¥ 495 M
    Land¥ 2 B¥ 2 B¥ 2 B¥ 2 B
    Construction in progress¥ 276 M¥ 60 M¥ 1 M
     Other¥ 2 B¥ 1 B¥ 1 B¥ 2 B
      Accumulated depreciation¥ -1 B¥ -1 B¥ -1 B¥ -1 B
      Other, net¥ 299 M¥ 281 M¥ 206 M¥ 200 M
    Property, plant and equipment¥ 5 B¥ 5 B¥ 4 B¥ 5 B
    Software¥ 66 M¥ 107 M¥ 89 M¥ 89 M
     Other¥ 7 M¥ 7 M¥ 7 M¥ 13 M
    Intangible assets¥ 73 M¥ 114 M¥ 96 M¥ 102 M
     Investment securities¥ 6 B¥ 6 B¥ 8 B¥ 7 B
     Deferred tax assets¥ 375 M¥ 637 M¥ 318 M¥ 432 M
     Other¥ 236 M¥ 292 M¥ 226 M¥ 242 M
      Allowance for doubtful accounts¥ -13 M¥ -44 M¥ -17 M¥ -26 M
    Investments and other assets¥ 7 B¥ 6 B¥ 9 B¥ 7 B
   Noncurrent assets¥ 12 B¥ 12 B¥ 14 B¥ 13 B
  Assets¥ 26 B¥ 26 B¥ 27 B¥ 27 B
   Notes and accounts payable-trade¥ 1 B¥ 1 B¥ 1 B¥ 1 B
    Provision for bonuses¥ 263 M¥ 246 M¥ 223 M¥ 218 M
    Provision for directors' bonuses¥ 14 M¥ 15 M¥ 14 M¥ 25 M
    Provision for sales returns¥ 24 M¥ 12 M¥ 2 M¥ 2 M
    Income taxes payable¥ 232 M¥ 102 M¥ 639 M¥ 411 M
   Other¥ 760 M¥ 585 M¥ 451 M¥ 640 M
   Current liabilities¥ 2 B¥ 2 B¥ 2 B¥ 2 B
    Provision for retirement benefits¥ 365 M¥ 363 M¥ 394 M¥ 404 M
    Long-term accounts payable-other¥ 129 M¥ 111 M¥ 75 M¥ 66 M
    Other¥ 378 M¥ 375 M¥ 382 M¥ 386 M
   Noncurrent liabilities¥ 873 M¥ 850 M¥ 851 M¥ 857 M
  Liabilities¥ 3 B¥ 3 B¥ 3 B¥ 3 B
   Capital stock¥ 4 B¥ 4 B¥ 4 B¥ 4 B
    Capital surplus¥ 5 B¥ 5 B¥ 5 B¥ 5 B
    Retained earnings¥ 13 B¥ 13 B¥ 14 B¥ 14 B
   Treasury stock¥ -94 M¥ -95 M¥ -96 M¥ -96 M
   Shareholders' equity¥ 23 B¥ 23 B¥ 23 B¥ 24 B
   Valuation difference on available-for-sale securities¥ -156 M¥ -629 M¥ -163 M¥ -284 M
   Valuation and translation adjustments¥ -156 M¥ -629 M¥ -163 M¥ -284 M
  Net assets¥ 23 B¥ 22 B¥ 23 B¥ 24 B
 Liabilities and net assets¥ 26 B¥ 26 B¥ 27 B¥ 27 B
   Inventories¥ 2 B
Consolidated :Income statement (Annual ) 2008-03-312009-03-312010-03-312011-03-31
   Net sales¥ 14 B¥ 14 B¥ 12 B¥ 13 B
   Cost of sales¥ 7 B¥ 7 B¥ 6 B¥ 6 B
    Advertising expenses¥ 100 M¥ 89 M¥ 88 M¥ 75 M
    Bonuses¥ 355 M¥ 351 M¥ 285 M¥ 300 M
    Depreciation¥ 132 M¥ 129 M¥ 139 M¥ 118 M
    Provision for bonuses¥ 174 M¥ 167 M¥ 140 M¥ 136 M
    Provision for directors' bonuses¥ 14 M¥ 15 M¥ 14 M¥ 25 M
    Retirement benefit expenses¥ 115 M¥ 135 M¥ 133 M¥ 103 M
    Research and development expenses¥ 877 M¥ 749 M¥ 754 M¥ 685 M
    Salaries and allowances¥ 1 B¥ 1 B¥ 1 B¥ 1 B
    Rent expenses¥ 229 M¥ 197 M¥ 121 M¥ 117 M
    Promotion expenses¥ 835 M¥ 771 M¥ 536 M¥ 633 M
    Packing and transportation expenses¥ 541 M¥ 532 M¥ 339 M¥ 344 M
    Other¥ 1 B¥ 1 B¥ 1 B¥ 1 B
    Selling, general and administrative expenses¥ 6 B¥ 5 B¥ 4 B¥ 4 B
 Gross profit¥ 7 B¥ 6 B¥ 6 B¥ 6 B
  Gross profit-net¥ 7 B¥ 7 B¥ 6 B¥ 6 B
   Provision for sales returns¥ 24 M¥ 12 M¥ 2 M¥ 2 M
   Reversal of provision for sales returns¥ 35 M¥ 24 M¥ 12 M¥ 2 M
 Operating income¥ 1 B¥ 1 B¥ 1 B¥ 1 B
  Interest income¥ 138 M¥ 115 M¥ 122 M¥ 121 M
  Dividends income¥ 159 M¥ 154 M¥ 139 M¥ 165 M
  Gain on sales of investment securities¥ 2 M¥ 170 M¥ 126 M
  Gain on investments in partnership¥ 57 M¥ 49 M¥ 14 M
  Gain on valuation of derivatives¥ 21 M¥ 36 M
  Miscellaneous income¥ 59 M¥ 38 M¥ 52 M¥ 53 M
  Non-operating income¥ 475 M¥ 358 M¥ 521 M¥ 503 M
  Interest expenses¥ 231 K¥ 2 M¥ 1 M¥ 1 M
  Loss on investments in partnership¥ 45 M
  Miscellaneous loss¥ 165 K¥ 297 K¥ 207 K¥ 2 M
  Non-operating expenses¥ 149 M¥ 222 M¥ 1 M¥ 48 M
 Ordinary income¥ 1 B¥ 1 B¥ 1 B¥ 2 B
  Gain on sales of noncurrent assets¥ 1 M¥ 2 M
  Reversal of allowance for doubtful accounts¥ 517 K
  Surrender value of insurance¥ 728 K
  Extraordinary income¥ 25 M¥ 66 M¥ 3 M
  Loss on disaster¥ 114 M
  Loss on disposal of noncurrent assets¥ 12 M¥ 27 M¥ 11 M¥ 5 M
  Loss on valuation of investment securities¥ 158 M¥ 607 M¥ 219 M¥ 36 M
  Other¥ 2 M
  Extraordinary loss¥ 171 M¥ 652 M¥ 230 M¥ 200 M
 Income before income taxes¥ 1 B¥ 837 M¥ 1 B¥ 2 B
 Income taxes¥ 570 M¥ 388 M¥ 755 M¥ 818 M
  Income taxes-current¥ 469 M¥ 321 M¥ 755 M¥ 796 M
  Income taxes-deferred¥ 101 M¥ 67 M¥ -867 K¥ 21 M
 Income before minority interests¥ 1 B
 Net income¥ 794 M¥ 449 M¥ 920 M¥ 1 B
  Valuation difference on available-for-sale securities¥ -121 M
  Other comprehensive income¥ -121 M
 Comprehensive income¥ 1 B
   Comprehensive income attributable to owners of the parent¥ 1 B
   Comprehensive income attributable to minority interests
  Loss on valuation of derivatives¥ 110 M¥ 132 M
  Provision of allowance for doubtful accounts¥ 30 M
  Gain on sales of investment securities¥ 23 M¥ 66 M
  Loss on valuation of inventories¥ 17 M
    Provision for directors' retirement benefits¥ 7 M
  Loss on abandonment of inventories¥ 37 M
  Gain on redemption of investment securities¥ 57 M
  Loss on redemption of investment securities¥ 57 M
Consolidated :Cash flow statement (Annual ) 2008-03-312009-03-312010-03-312011-03-31
  Subtotal¥ 1 B¥ 1 B¥ 2 B¥ 2 B
   Depreciation and amortization¥ 482 M¥ 572 M¥ 585 M¥ 519 M
   Amortization of goodwill¥ 61 M
   Interest and dividends income¥ -298 M¥ -269 M¥ -262 M¥ -286 M
   Interest expenses¥ 231 K¥ 2 M¥ 1 M¥ 1 M
   Decrease (increase) in notes and accounts receivable-trade¥ 219 M¥ -129 M¥ 371 M¥ 151 M
   Decrease (increase) in inventories¥ 12 M¥ -60 M¥ 128 M¥ 270 M
   Increase (decrease) in notes and accounts payable-trade¥ 103 M¥ -96 M¥ -142 M¥ -164 M
   Loss (gain) on sales of investment securities¥ -26 M¥ -66 M¥ -170 M¥ -126 M
   Increase (decrease) in provision¥ -519 M¥ 3 M¥ -38 M¥ 11 M
   Loss (gain) on valuation of investment securities¥ 158 M¥ 607 M¥ 219 M¥ 36 M
   Loss (gain) on valuation of derivatives¥ 110 M¥ 132 M¥ -21 M¥ -36 M
   Loss (gain) on sales of noncurrent assets¥ -1 M¥ -2 M
   Loss on disaster¥ 114 M
   Other, net¥ 23 M¥ -43 M¥ 46 M¥ 16 M
  Interest and dividends income received¥ 275 M¥ 277 M¥ 264 M¥ 295 M
  Interest expenses paid¥ -620 K¥ -21 K¥ -868 K
  Income taxes paid¥ -469 M¥ -446 M¥ -232 M¥ -1 B
  Net cash provided by (used in) operating activities¥ 1 B¥ 1 B¥ 2 B¥ 1 B
  Purchase of property, plant and equipment¥ -900 M¥ -690 M¥ -118 M¥ -153 M
  Proceeds from sales of property, plant and equipment¥ 5 M¥ 145 K¥ 9 M
  Purchase of investment securities¥ -2 B¥ -1 B¥ -3 B¥ -908 M
  Proceeds from sales and redemption of securities¥ 1 B¥ 1 B¥ 546 M¥ 389 M
  Proceeds from sales and redemption of investment securities¥ 568 M¥ 551 M¥ 1 B¥ 539 M
  Purchase of intangible assets¥ -3 M¥ -33 M¥ -33 M¥ -44 M
  Purchase of investments in subsidiaries resulting in change in scope of consolidation¥ -742 M
  Net cash provided by (used in) investing activities¥ -283 M¥ -1 B¥ -195 M¥ -602 M
  Decrease in short-term loans payable¥ -79 M
  Repayment of long-term loans payable¥ -212 M
  Cash dividends paid¥ -425 M¥ -426 M¥ -447 M¥ -513 M
  Repayments of lease obligations¥ -2 M¥ -4 M¥ -6 M
  Decrease (increase) in treasury stock¥ -910 K¥ -984 K¥ -710 K¥ -523 K
  Net cash provided by (used in) financing activities¥ -425 M¥ -430 M¥ -453 M¥ -814 M
 Net increase (decrease) in cash and cash equivalents¥ 452 M¥ -822 M¥ 1 B¥ 210 M
 Cash and cash equivalents¥ 2 B¥ 2 B¥ 3 B¥ 3 B
Consolidated :Shareowners' equity (Annual ) 2008-03-312009-03-312010-03-312011-03-31
    Total changes of items during the period
     Disposal of treasury stock¥ 8 K
     Total changes of items during the period¥ 88 K¥ 61 K¥ 8 K
     Dividends from surplus¥ -425 M¥ -425 M¥ -447 M¥ -515 M
     Total changes of items during the period¥ 368 M¥ 23 M¥ 472 M¥ 756 M
    Purchase of treasury stock¥ -1 M¥ -1 M¥ -815 K¥ -523 K
    Disposal of treasury stock¥ 290 K¥ 483 K¥ 96 K
    Total changes of items during the period¥ -998 K¥ -1 M¥ -718 K¥ -523 K
    Dividends from surplus¥ -425 M¥ -425 M¥ -447 M¥ -515 M
    Net income¥ 794 M¥ 449 M¥ 920 M¥ 1 B
    Purchase of treasury stock¥ -1 M¥ -1 M¥ -815 K¥ -523 K
    Disposal of treasury stock¥ 378 K¥ 544 K¥ 104 K
    Total changes of items during the period¥ 367 M¥ 22 M¥ 471 M¥ 756 M
    Net changes of items other than shareholders' equity¥ -515 M¥ -473 M¥ 466 M¥ -121 M
    Total changes of items during the period¥ -515 M¥ -473 M¥ 466 M¥ -121 M
    Net changes of items other than shareholders' equity¥ -515 M¥ -473 M¥ 466 M¥ -121 M
    Total changes of items during the period¥ -515 M¥ -473 M¥ 466 M¥ -121 M
   Dividends from surplus¥ -425 M¥ -425 M¥ -447 M¥ -515 M
   Net income¥ 794 M¥ 449 M¥ 920 M¥ 1 B
   Purchase of treasury stock¥ -1 M¥ -1 M¥ -815 K¥ -523 K
   Disposal of treasury stock¥ 378 K¥ 544 K¥ 104 K
   Net changes of items other than shareholders' equity¥ -515 M¥ -473 M¥ 466 M¥ -121 M
   Total changes of items during the period¥ -147 M¥ -450 M¥ 938 M¥ 635 M
     Disposal of treasury stock¥ 88 K¥ 61 K¥ 8 K

Free Download

*Free Download Financial Statement dataMember limited service.

[Data] Balance sheet, Income statement, Cash flow statement, Shareowners' equity (*Consolidated or Non-Consolidated. two or more terms)

Sponsored Link

Related Information: Nissui Pharmaceutical (Annual )

Statement Type
Annual : Nissui Pharmaceutical
First quarter : Nissui Pharmaceutical
Second quarter : Nissui Pharmaceutical
Third quarter : Nissui Pharmaceutical
Analysis Menu
@Outline : Nissui Pharmaceutical
@Statement : Nissui Pharmaceutical
@Rating : Nissui Pharmaceutical
@Indicator : Nissui Pharmaceutical
@Download : Nissui Pharmaceutical
Industry Comparison Ranking
Chemicals - EDIUNET Industry Rankings
Chemicals - EDIUNET Credit Rating
Chemicals - EDIUNET Industry Avg
Comparison with a neighboring company
Tokyo - EDIUNET Prefectures
Tokyo台東区 - EDIUNET Prefectures

Related company's newest statement

Date Company Credit Rating Date
1/23 Milbon AA→AAA 2013-12-20
1/17 Kawaguchi Chemical Indu.. BBB→BB 2013-11-30
1/17 SANKEI CHEMICAL A 2013-11-30
1/15 HOKKO CHEMICAL INDUSTRY BB→B 2013-11-30
1/15 Daito Pharmaceutical Co . AA 2013-11-30 (Q2)
1/15 KAWAKAMI PAINT MFG. B→BB 2013-11-30
1/15 旭化学工業 AA 2013-11-30 (Q1)
1/10 OSAKA ORGANIC CHEMICAL .. BB→BBB 2013-11-30
1/10 HISAMITSU PHARMACEUTICAL A 2013-11-30 (Q3)
1/10 AMS Life Science BBB→BB 2013-11-30 (Q1)

Ticker Market Industry Month report Rating
@ Nissui Pharmaceutical 4550 TSE 1st Chemicals 3 Annual AA

Related Company

@ KUREHA (Sales ¥ 130 B) +
@ KAKEN PHARMACEUTICAL (Sales ¥ 87 B) +
@ JSP (Sales ¥ 96 B) +
@ FUJIKURA KASEI (Sales ¥ 53 B) +
@ 日油 (Sales ¥ 148 B) +
@ NITTO FC (Sales ¥ 18 B) +
@ Daito Pharmaceutical Co . (Sales ¥ 28 B) +
@ DAINICHISEIKA COLOR & CHEMICALS MFG. (Sales ¥ 151 B) +
@ ZERIA PHARMACEUTICAL (Sales ¥ 53 B) +
@ Eisai (Sales ¥ 573 B) +
@ SATO PHARMACEUTICAL (Sales ¥ 38 B) +
@ DAISO (Sales ¥ 83 B) +
@ 日本新薬 (Sales ¥ 69 B) +

関連する株式投資情報

EDIUNET Caution

*Financial data might be different from the actual one. Please confirm the original, and read Caution.

*This site has obtained the information from the FSA's EDINET, Tokyo Stock Exchange's TDnet and Pay statistical data services, Fukuoka stock Exchange's Stock market capitalization, Center for Spatial Information Science's CSV Geocoding Service. The copyright of the information belongs to each corporation etc. .

▲ Go to the top ▲

  1. Guide
  2. Mobile
  3. Tablet
  4. Japanese
`EDIUNET` Copyright©2006-2024 `MAバンク` (0.132 sec.)